Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | tert-Butyl 4-oxopiperidine-1-carboxylate | HCID 735900 | — |
| Reactant | HCID 86623906 | HCID 86623906 | — |
| Catalyst | 15-Crown-5 | HCID 36336 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 24967275 | HCID 24967275 | 96% |
Reaction Steps
tert-Butyl 4-(3-ethoxy-5-(5-(trifluoromethyl)pyridin-2-yloxy)benzylidene)piperidine-1-carboxylate [3-(5-Trifluoromethyl-pyridin-2-yloxy)-benzyl]-phosphonic acid diethyl ester (395 mg, 0.911 mmol) from Step 4 and 1,4,7,10,13-pentaoxacyclopentadecane (15-Crown-5, 0.003 mL, 0.0182 mmol) were combined in THF (3 mL). Sodium hydride (40 mg, 60% dispersion in mineral oil, 1.0 mmol) was added and the mixture was stirred for 30 min. A solution of 4-oxo-piperidine-1-carboxylic acid tert-butyl ester (200 mg, 1.0 mmol) in THF (2 mL) was added and the reaction was stirred at room temperature. After 16 h, water was added and the layers were separated. The aqueous layer was extracted with EtOAc and the combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated to afford the title compound as a thick oil (436 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08044052B2 |
|---|
| Source dataset | uspto-grants-2011_10 |
|---|
| ORD ID | ord-4cae50d1f73e4e0393abd1b4965066f6 |
|---|
| Source note | uspto-grants-2011_10 |
|---|